Literature DB >> 20215095

[Sleep disturbances in Alzheimer's disease and other dementias].

Marie-Françoise Vecchierini1.   

Abstract

Sleep in dementias has been mainly studied in Alzheimer disease (AD). Sleep disturbances are found in 25 to 35% of subjects with AD. Subjective and objective disturbances are described. Long nocturnal awakenings disrupt sleep; total sleep time and sleep efficiency are reduced. Slow wave sleep is decreased and sometimes disappears. REM sleep percentage is also reduced and at a later stage of the disease, REM latency is increased. Sleep fragmentation can be associated with excessive daytime napping and sleepiness, and with other behavioral symptoms such as the sundowning syndrome and nocturnal agitation. Sleep abnormalities closely parallel the level of severity of dementia. The rest/activity ratio and the sleep-wake rhythms are more and more disturbed; the phase delay of the temperature rhythm is associated with the severity of the sundowning syndrome. Sleep disturbances and behavioral symptoms are the main reasons to institutionalize the patient. Sleep disturbances are related to multiple factors. Pathophysiological changes resulting of the disease itself, such as damage to the cholinergic pathways and to the circadian pacemaker in the suprachiasmatic nucleus, contribute to sleep changes in AD. Associated medical and psychiatric illness and their different treatments as well as environmental factors also induced sleep disturbances. Sleep-disordered breathing is a highly prevalent condition in AD patients and restless leg syndrome may account for nocturnal agitation. In Parkinson and in Lewy body dementias, sleep disturbances are more severe than in DA and REM sleep behavior disorder can precede by several years these diseases. Sleep attacks and sleepiness are very frequent in Parkinson disease. Specific etiologies should drive specific treatment. Several non pharmacologic treatments are usually associated to treat sleep disturbances in AD: information, increased daytime physical, social activities to minimize daytime naps and exposure to bright light. Some studies found advantages to associate melatonin in the evening.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215095     DOI: 10.1684/pnv.2010.0203

Source DB:  PubMed          Journal:  Psychol Neuropsychiatr Vieil        ISSN: 1760-1703


  9 in total

1.  A sleep continuity scale in Alzheimer's disease: validation and relationship with cognitive and functional deterioration.

Authors:  R Manni; E Sinforiani; C Zucchella; M Terzaghi; C Rezzani
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

2.  Sleep disorders in machado-joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-related motor and non-motor features.

Authors:  José Luiz Pedroso; Pedro Braga-Neto; André Carvalho Felício; Lívia Almeida Dutra; William A C Santos; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

3.  Sleep and diurnal rest-activity rhythm disturbances in a mouse model of Alzheimer's disease.

Authors:  Mikolaj J Filon; Eli Wallace; Samantha Wright; Dylan J Douglas; Lauren I Steinberg; Carissa L Verkuilen; Pamela R Westmark; Rama K Maganti; Cara J Westmark
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

4.  Relation between caffeine and behavioral symptoms in elderly patients with dementia: an observational study.

Authors:  M A Kromhout; J Jongerling; W P Achterberg
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

5.  Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.

Authors:  Venkatramanujam Srinivasan; Charanjit Kaur; Seithikurippu Pandi-Perumal; Gregory M Brown; Daniel P Cardinali
Journal:  Int J Alzheimers Dis       Date:  2010-12-08

6.  Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages.

Authors:  Jessica Colby-Milley; Chelsea Cavanagh; Sonia Jego; John C S Breitner; Rémi Quirion; Antoine Adamantidis
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

7.  REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment.

Authors:  Stuart J McCarter; Grace M Tabatabai; Ho-Yann Jong; David J Sandness; Paul C Timm; Katie L Johnson; Allison R McCarter; Rodolfo Savica; Prashanthi Vemuri; Mary M Machulda; Kejal Kantarci; Michelle M Mielke; Bradley F Boeve; Michael H Silber; Erik K St Louis
Journal:  Neurology       Date:  2019-12-12       Impact factor: 9.910

8.  Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson's disease.

Authors:  Samuel J Bolitho; Sharon L Naismith; Pierre Salahuddin; Zoe Terpening; Ron R Grunstein; Simon J G Lewis
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

9.  Rest-activity rhythms in small scale homelike care and traditional care for residents with dementia.

Authors:  Jeroen S Kok; Ina J Berg; Gerwin C G Blankevoort; Erik J A Scherder
Journal:  BMC Geriatr       Date:  2017-07-05       Impact factor: 3.921

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.